Tosoh Bioscience announces US FDA 510(k) clearance for its next-generation HbA1c testing system, the Tosoh Automated Glycohemoglobin Analyzer HLC 723-GR01. Intended for monitoring the long-term blood glucose control of individuals with diabetes, the system can also aid in the diagnosis of diabetes and help identify individuals who may be at risk of developing the disease. With a compact footprint, the GR01 is a fully automated analyzer that harnesses Tosoh’s proprietary non-porous ion exchange HPLC column technology to deliver A1c results in 50 seconds, while also detecting common hemoglobin variants. The system can be used in both mid- and high-volume laboratories and is designed for walkaway operation while offering user-friendly capabilities to help laboratories save time and labor. The GR01 has an intuitive user interface and can integrate with the LIS.